ArticleJournal of neuropsychology2026
Psychometric validation of the Spanish version of the parent-reported developmental profile 3 (DP-3).
Article in Journal of neuropsychology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychometric validation of the Spanish version of the parent-reported developmental profile 3 (DP-3).Journal of neuropsychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurodevelopmental assessment in childhood is essential in educational, clinical, and research contexts to establish benchmarks and detect early signs of neurodevelopmental disorders. The Developmental Profile 3 (DP-3) is a parent-reported screening tool for measuring neurodevelopment in the general population, though its Spanish adaptation has not been independently assessed. This study evaluated the psychometric properties of the Spanish DP-3 in 440 toddlers (47.7% female; 78.4% European ethnicity; mean age 29.8 months) from Barcelona, Spain, based on data collected between March 2022 and March 2024. The DP-3 demonstrated good internal consistency (Cronbach's alpha > .7) and acceptable to moderate internal structure fit (CFI = .924, TLI = .848). High sensitivity to developmental change across all scales was observed in repeated assessments of a subset of participants. Construct validity was supported by associations with child age, number of siblings, maternal logical reasoning and educational level, and breastfeeding, along with moderate correlations with the corresponding subscales of the Bayley Scales of Infant and Toddler Development III (r = -.01; .48). These findings support the Spanish version of the DP-3 as a reliable and valid instrument for assessing neurodevelopment in Spanish toddlers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.